Whitening Agent And Skin External Preparation

a technology of external preparation and whitening agent, which is applied in the direction of biocide, heterocyclic compound active ingredients, drug compositions, etc., can solve the problems of insufficient safety, unreachable literature, and insufficient effect of whitening agent, and achieve excellent inhibitory action on melanin production and low cytotoxicity

Inactive Publication Date: 2010-12-23
AMAZON TECH INC +1
View PDF8 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0046]The whitening agent of the present invention has an excellent inhibitory action on melanin production and also has extremely low cytotoxicity; therefore, it can be suitably mixed into a skin external preparation as a whitening agent.

Problems solved by technology

However, a whitening agent fully satisfactory in terms of the effect, safety, and the like has not yet been obtained, and therefore development of a new whitening agent has been demanded.
However, these literatures are totally silent on an inhibitory action on the melanin production and a whitening effect.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Whitening Agent And Skin External Preparation
  • Whitening Agent And Skin External Preparation
  • Whitening Agent And Skin External Preparation

Examples

Experimental program
Comparison scheme
Effect test

synthesis example 1-1

Synthesis of 4-(5,5-dimethyl-4,5-dihydrothiazol-2-yl amino)phenol (Compound 41)

[0103]To p-anisidine (0.60 g, 4.86 mmol) and methanol (4.0 mL) in a 50 mL recovery flask was added methallyl isothiocyanate (0.50 g, 4.42 mmol) dropwise at room temperature, and then the resulting mixture was stirred for 12 hours at room temperature. Upon completion of the reaction, the mixture was extracted with ethyl acetate once. The organic phase thus obtained was washed with saturated brine and then dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure and the residue was recrystallized from a mixed solvent of ethyl acetate and hexane to give 0.79 g of 1-(4-methoxyphenyl)-3-(2- methylallyl)thiourea (yield 76%).

[0104]1-(4-Methoxyphenyl)-3-(2-methylallyl)thiourea (0.50 g, 2.11 mmol) and 35% hydrochloric acid (5.0 mL) were added in a pressure resistant reaction container, and the resulting mixture was stirred at 140° C. for five hours in the sealed container. Upon ...

synthesis example 1-2

Synthesis of (hetero)arylaminothiazolines

[0105](Hetero)arylaminothiazolines as shown in Table 6 were each synthesized in the same manner as in Synthesis Example 1-1 except that raw material A was used instead of anisidine.

TABLE 6No.StructureRaw material ANMRYield41p-anisidine1H-NMR (DMSO-d6): 1.46 (6 H, s), 3.51 (2 H, br-s), 6.61 (2 H, dd), 7.07 (2 H, br-s), 8.67 (2 H, br-s)40%42m-anisidine1H-NMR (DMSO-d6): 1.47 (6 H, s), 3.64 (2 H, br-s), 6.31 (1 H, d), 6.83 (2 H, br-s), 6.97 (1 H, t), 9.17 (2 H, br-s)34%383-aminopyridine1H-NMR (DMSO-d6): 1.49 (6 H, s), 3.53 (2 H, br-s), 7.23 (1 H, dd), 7.66 (1 H, br-s), 8.12 (1 H, dd), 8.35 (1 H, br-s), 9.10 (1 H, br-s)56%

synthesis example 2

Synthesis of 4-(pyridin-2-yl)-N-o-toluylthiazol-2-amine (Compound 2)

[0106]To 975 mL of methanol were added triethylamine (14.0 g, 137 mmol), o-toluylthiourea (11.54 g, 69.4 mmol), and 2-(bromoacetyl)pyridine hydrobromide (19.5 g, 69.4 mmol), and the resulting mixture was stirred for 15 hours at room temperature. Upon completion of the reaction, 1,950 mL of water was added to the mixture and precipitated crystals were collected by filtration. The solid thus collected was crystallized from a mixed solvent of water and methanol to give the title compound (14.0 g, 76%).

[0107]1H-NMR (DMSO-d6): 2.30(3H, s), 7.01-7.04(1H, m), 7.22-7.30(3H, m), 7.46(1H, s), 7.82-7.91(2H, m), 7.97(1H, d), 8.56(1H, d), 9.32(1H, s)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
excitation wavelengthaaaaaaaaaa
excitation wavelengthaaaaaaaaaa
Raaaaaaaaaaa
Login to view more

Abstract

The present invention provides a compound having an excellent inhibitory action on melanin production and being useful as a whitening agent, and a skin external preparation containing the compound. The whitening agent of the present invention comprises, as an active ingredient, a heterocyclic compound represented by formula (1) or a pharmacologically acceptable salt thereof:wherein A is C1-6 alkyl, C5-6 cycloalkyl, benzyl, benzylcarbonyl, benzoyl, phenyl, pyridyl or pyrimidyl; Ra is H, C1-6 alkyl, or C2-6 alkenyl; “” represents a single bond or a double bond wherein n=1 or 2; Y is S or O; and R3 and R4 are each independently H, C1-6 alkyl, hydroxy-C1-6 alkyl, C2-7 acyl, phenyl, pyridyl, pyrimidyl, etc.;with the proviso that at least one R3 is a group other than C1-3 alkyl in the case where: the hetero ring containing Y is a thiazoline ring; R4═Ra═H; X1═X2═CH; and either p =0 or R5═C1-6 alkyl.

Description

RELATED APPLICATIONS[0001]This application claims the priority of Japanese Patent Application No. 2008-29106 filed on Feb. 8, 2008 and Japanese Patent Application No. 2008-199606 filed on Aug. 1, 2008, which are incorporated herein by reference.FIELD OF THE INVENTION[0002]The present invention relates to a whitening agent and a skin external preparation, and particularly, to an active ingredient thereof.BACKGROUND OF THE INVENTION[0003]Pigmentation in the skin such as pigmented spots and freckles are resulted from hyperpigmentation of melanin in the epidermis. The hyperpigmentation is caused by acceleration of melanin production in epidermal melanocytes triggered by hormone abnormality or UV stimulation.[0004]A whitening agent has been mixed into a skin external preparation with an aim to prevent and improve such abnormal melanin pigmentation. At present, as ingredients that are mixed into a skin external preparation as a whitening agent, there are vitamin C derivative, kojic acid, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K8/49C07D277/18C07D417/12A61Q19/02
CPCA61K8/4946A61Q19/02A61K31/506A61K31/4439A61P1/00A61P17/00A61P17/16A61P19/02
Inventor HANYU, NAOTOSAITO, TOMOKOSHIBATA, TAKAKOSATO, KIYOSHIOGINO, KIMIHIRO
Owner AMAZON TECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products